News
A study of real-world and virtual patients suggests that a less frequent dosing of glucagon-like peptide 1 receptor agonists ...
We are just starting to learn more about the systemic impact of these medications,” Dr. Shiara Ortiz-Pujols told The Post.
The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other ...
Although coverage restrictions remain in place, the trendiness of weight loss drugs may be creating a growing cost concern ...
Another challenge is brewing for restaurants. It’s not the economy, another global disease, or a weather disaster. It’s the ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...
The percentage of adult patients with a diagnosis of overweight or obesity increased from 10.4% in 2019 to 15.7% in 2024.
A consensus statement from the Society for Perioperative Assessment and Quality Improvement recommends patients should ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback